Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 2
2010 1
2011 3
2020 1
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.
van de Borne P, Peeters A, Janssens L, Leone A, Lemmens R, Verhaegen A, De Meulemeester M, Balthazar Y, Heijmans S, Calozet Y, Paquot N, Carlier S, Hemelsoet D, Bray S, Ray KK. van de Borne P, et al. Among authors: de meulemeester m. Acta Cardiol. 2022 Apr 20:1-10. doi: 10.1080/00015385.2022.2030568. Online ahead of print. Acta Cardiol. 2022. PMID: 35442151 Free article.
Positional cloning of genes involved in the Beckwith-Wiedemann syndrome, hemihypertrophy, and associated childhood tumors.
Mannens M, Alders M, Redeker B, Bliek J, Steenman M, Wiesmeyer C, de Meulemeester M, Ryan A, Kalikin L, Voûte T, De Kraker J, Hoovers J, Slater R, Feinberg A, Little P, Westerveld A. Mannens M, et al. Among authors: de meulemeester m. Med Pediatr Oncol. 1996 Nov;27(5):490-4. doi: 10.1002/(SICI)1096-911X(199611)27:5<490::AID-MPO17>3.0.CO;2-E. Med Pediatr Oncol. 1996. PMID: 8827079 Review.
Comparative genomic hybridization analysis of Wilms tumors.
Steenman M, Redeker B, de Meulemeester M, Wiesmeijer K, Voûte PA, Westerveld A, Slater R, Mannens M. Steenman M, et al. Among authors: de meulemeester m. Cytogenet Cell Genet. 1997;77(3-4):296-303. doi: 10.1159/000134602. Cytogenet Cell Genet. 1997. PMID: 9284942
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.
Schlesinger N, Mysler E, Lin HY, De Meulemeester M, Rovensky J, Arulmani U, Balfour A, Krammer G, Sallstig P, So A. Schlesinger N, et al. Among authors: de meulemeester m. Ann Rheum Dis. 2011 Jul;70(7):1264-71. doi: 10.1136/ard.2010.144063. Epub 2011 May 3. Ann Rheum Dis. 2011. PMID: 21540198 Free PMC article. Clinical Trial.
Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study.
Schlesinger N, De Meulemeester M, Pikhlak A, Yücel AE, Richard D, Murphy V, Arulmani U, Sallstig P, So A. Schlesinger N, et al. Among authors: de meulemeester m. Arthritis Res Ther. 2011 Mar 25;13(2):R53. doi: 10.1186/ar3297. Arthritis Res Ther. 2011. PMID: 21439048 Free PMC article. Clinical Trial.